Research Article
Prescription of Kampo Drugs in the Japanese Health Care Insurance Program
Table 2
Distributions of the usage of Kampo drugs for sex, patient type, and age.
| Drug | Total1 | Sex2 | Patient | Age | Male | Female | Inpatient | Outpatient | 0–9 | 10–19 | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | 80–89 | 90–98 |
| All | 67,095,008 | 42.81% | 57.19% | 2.88% | 97.12% | 9.05% | 4.70% | 5.28% | 7.86% | 7.82% | 11.19% | 18.58% | 21.75% | 11.82% | 1.95% | Kampo | 898,797 | 33.09% | 66.91% | 7.01% | 92.99% | 1.57% | 1.76% | 6.89% | 9.80% | 10.69% | 9.85% | 17.55% | 23.81% | 15.49% | 2.59% |
|
|
Kampo drugs were perscribed for patients of the total number of prescription. For male, Kampo drugs were prescribed for patients. For female .
|